SpringWorks Therapeutics Reports Third Quarter 2022
– Presented Positive Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for...
Baden Wüberg Bernd Kasper Malin Hultcrantz Saqib Islam Belantamab Mafodotin Belamaf Development Rd Expenses
Source: globenewswire.com